Literature DB >> 8420971

A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.

D Kohda1, M Odaka, I Lax, H Kawasaki, K Suzuki, A Ullrich, J Schlessinger, F Inagaki.   

Abstract

Elucidation of the three-dimensional structure of the complex of the epidermal growth factor (EGF) and its receptor is essential for understanding the molecular mechanisms of the EGF-receptor interaction and EGF-induced receptor-receptor interaction. NMR is useful to investigate interactions in solution between macromolecules at atomic resolution, but has a limitation in molecular masses of target proteins: less than 300 residues. We have prepared a fragment with apparent molecular mass of 40 kDa in SDS gels from the soluble extracellular domain of the EGF receptor (sEGFR, 619 residues) by sequential limited proteolysis with proteinase K and bromelain. This fragment is a monomeric structural domain consisting of 202 amino acid residues (Cys302-Arg503) and 18-kDa sugar chains, and binds EGF and transforming growth factor-alpha (TGF alpha). This 40-kDa domain has a dissociation constant of about 1 microM for human TGF alpha, which is similar to that of the parental sEGFR. sEGFR oligomerizes in response to EGF and TGF alpha, while the 40-kDa domain does not, suggesting that the sequences other than this domain is required for receptor oligomerization. The 40-kDa ligand-binding domain described in this report is suitable for analysis by various physico-chemical approaches such as NMR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420971

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.

Authors:  Victoria P Ramsauer; Vanessa Pino; Amjad Farooq; Coralie A Carothers Carraway; Pedro J I Salas; Kermit L Carraway
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

Review 2.  Reversion of the ErbB malignant phenotype and the DNA damage response.

Authors:  E Aaron Runkle; Hongtao Zhang; Zheng Cai; Zhiqiang Zhu; Barry L Karger; Shiaw-Lin Wu; Donald M O'Rourke; Zhaocai Zhou; Qiang Wang; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2012-09-27       Impact factor: 3.362

3.  Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.

Authors:  R N Jorissen; V C Epa; H R Treutlein; T P Garrett; C W Ward; A W Burgess
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

4.  Two EGF molecules contribute additively to stabilization of the EGFR dimer.

Authors:  M A Lemmon; Z Bu; J E Ladbury; M Zhou; D Pinchasi; I Lax; D M Engelman; J Schlessinger
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

5.  N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes.

Authors:  Karol Kaszuba; Michał Grzybek; Adam Orłowski; Reinis Danne; Tomasz Róg; Kai Simons; Ünal Coskun; Ilpo Vattulainen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-24       Impact factor: 11.205

Review 6.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

7.  A structure-based model for ligand binding and dimerization of EGF receptors.

Authors:  Peter Klein; Dawn Mattoon; Mark A Lemmon; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

8.  Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization.

Authors:  Judith Schmiedel; Andree Blaukat; Shiqing Li; Thorsten Knöchel; Kathryn M Ferguson
Journal:  Cancer Cell       Date:  2008-04       Impact factor: 31.743

Review 9.  HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks.

Authors:  Ralf Landgraf
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules.

Authors:  C W Ward; T P Garrett
Journal:  BMC Bioinformatics       Date:  2001-07-27       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.